Transpact Enterprises Limited was incorporated as a Private Limited Company with the name 'Transpact Enterprises Private Limited' on May 12, 2013. Further, the status of the Company was changed into Public Limited and the name of the Company was changed to 'Transpact Enterprises Limited' on April 16, 2019.
The Company operates as a key player in India's capital markets, offering a comprehensive range of services including equity broking, investment advisory, portfolio management, and digital trading solutions. The primary business is dealing in shares, securities, commodities, currencies and their derivatives, Stock broker, Share broker, sub broker, authorized person, dealer, jobber, market maker, Investment brokers, Insurance broker, Underwriter, and to carry out brokerage of all and every kind whatsoever, portfolio manager, investment advisors, mutual funds, wealth management and other related services or any other business in any other manner.
Their core business is to carry on the business of consulting and advisory services on all aspects of corporate, financial and commercial matters including management consulting, debt structuring, debt advisory, project appraisals, or any related items or things, required by any person, corporate, firm or association of persons and to undertake related services in India or abroad.
The products include 'Vestibulator which is a compact, mechanized, innovative therapeutic healthcare device which is ergonomically designed to p ...rovide stimulations for vestibular, neuro- developmental and sensory integration therapy. Another product is 'Rehabsoft' which is a cloud-based therapy and rehabilitation software solution developed specifically to streamline and manage the therapy, rehab clinical documentation, nutrition schedule, administrative processes, and training and individual education plan.
Apart from these, one more product includes 'Vestibulator Chair' which is an ergonomically-designed compact vestibular therapy device for at home therapy of children suffering from vestibular dysfunction and developmental disorders.
The Company came up with a Public Issue by allotting 1,04,000 Equity Shares of face value of Rs 10 each and raised funds from public aggregating to Rs 1.35 Crore on 28 August, 2019.
FAQs on Transpact Enterprises Ltd
1. Can I buy Transpact Enterprises Ltd from PL Capital? ›
Yes, you can invest in Transpact Enterprises Ltd shares directly through PL Capital. Our platform provides a seamless and secure way to buy, hold, and track Transpact Enterprises Ltd stock along with other leading companies listed on the NSE and BSE. Simply open a Demat and trading account with PL Capital, and you’ll be able to trade Transpact Enterprises Ltd as well as diversify your portfolio across equities, mutual funds, IPOs, and more.
2. Does Transpact Enterprises Ltd pay dividends? ›
Transpact Enterprises Ltd does not currently pay dividends. Investors in this case primarily benefit from capital appreciation, where the value of the stock may rise over time depending on business growth and market conditions.
3. What is the current share price of Transpact Enterprises Ltd ? ›
As of
08-Apr-2026 , the share price for Transpact Enterprises Ltd. is ₹ on the NSE (Note: Prices are dynamic and update frequently during market hours).
4. What is the 52-week high and low of Transpact Enterprises Ltd ? ›
The 52-week high and low of Transpact Enterprises Ltd share price is ₹ - ₹ as of
08-Apr-2026 , .
